OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular-level strategic goals and repressors in Leishmaniasis – Integrated data to accelerate target-based heterocyclic scaffolds
M. Abirami, Banoth Karan Kumar, Faheem Faheem, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115471-115471
Open Access | Times Cited: 8
M. Abirami, Banoth Karan Kumar, Faheem Faheem, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115471-115471
Open Access | Times Cited: 8
Showing 8 citing articles:
Genomic Insight of Leishmania Parasite: In-Depth Review of Drug Resistance Mechanisms and Genetic Mutations
Krupanshi Bharadava, Tarun Kumar Upadhyay, R. S. Kaushal, et al.
ACS Omega (2024)
Open Access | Times Cited: 7
Krupanshi Bharadava, Tarun Kumar Upadhyay, R. S. Kaushal, et al.
ACS Omega (2024)
Open Access | Times Cited: 7
Recent developments on microwave-assisted organic synthesis of nitrogen- and oxygen-containing preferred heterocyclic scaffolds
Ghanshyam Tiwari, Ashish Khanna, Vinay Kumar Mishra, et al.
RSC Advances (2023) Vol. 13, Iss. 47, pp. 32858-32892
Open Access | Times Cited: 20
Ghanshyam Tiwari, Ashish Khanna, Vinay Kumar Mishra, et al.
RSC Advances (2023) Vol. 13, Iss. 47, pp. 32858-32892
Open Access | Times Cited: 20
32nd Annual GP2A Medicinal Chemistry Conference
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
Leishmaniasis y su Resistencia a Fármacos: Un Enfoque Bibliométrico
César Aníbal Barzola Gaibor
Estudios y Perspectivas Revista Científica y Académica (2025) Vol. 4, Iss. 4, pp. 2464-2512
Closed Access
César Aníbal Barzola Gaibor
Estudios y Perspectivas Revista Científica y Académica (2025) Vol. 4, Iss. 4, pp. 2464-2512
Closed Access
Putrescine Depletion in Leishmania donovani Parasites Causes Immediate Proliferation Arrest Followed by an Apoptosis-like Cell Death
John W. Johnston, Jonathan Taylor, Surbhi Nahata, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 137-137
Open Access
John W. Johnston, Jonathan Taylor, Surbhi Nahata, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 137-137
Open Access
Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?
Miguel Marín, M. Allué López, Laura Gallego‐Yerga, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1055-1120
Open Access | Times Cited: 6
Miguel Marín, M. Allué López, Laura Gallego‐Yerga, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1055-1120
Open Access | Times Cited: 6
Polyamine-Enriched Exosomes from Leishmania donovani Drive Host Macrophage Polarization via Immunometabolism Reprogramming
Prince Sebastian, Madhulika Namdeo, Moodu Devender, et al.
ACS Infectious Diseases (2024)
Closed Access | Times Cited: 1
Prince Sebastian, Madhulika Namdeo, Moodu Devender, et al.
ACS Infectious Diseases (2024)
Closed Access | Times Cited: 1
New ψ-Santonin Derivatives from Crossostephium chinense and Their Anti-Proliferative Activities against Leishmania major and Human Cancer Cells A549
Zhichao Wang, Yoshi Yamano, Susumu Kawakami, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 8108-8108
Open Access | Times Cited: 2
Zhichao Wang, Yoshi Yamano, Susumu Kawakami, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 8108-8108
Open Access | Times Cited: 2
